Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Quotient stock

Learn how to easily invest in Quotient stock.

Quotient is a medical devices business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 450 staff and has a trailing 12-month revenue of around $37.6 million.

How to buy Quotient stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – QTNT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Quotient stock price (NASDAQ: QTNT)

Use our graph to track the performance of QTNT stocks over time.

Quotient shares at a glance

Information last updated 2023-02-02.
Latest market close$0.06
52-week range$0.06 - $68.80
50-day moving average $0.66
200-day moving average $9.22
Wall St. target price$60.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.34

Buy Quotient stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Quotient stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quotient price performance over time

Historical closes compared with the close of $0.055 from 2023-02-07

1 week (2023-02-02) -25.88%
1 month (2023-01-09) -80.43%
3 months (2022-11-09) -96.56%
6 months (2022-08-09) -77.08%
1 year (2022-02-09) -96.47%
2 years (2021-02-09) -98.92%
3 years (2020-02-07) 7.13
5 years (2018-02-09) 144

Quotient financials

Revenue TTM $37.6 million
Gross profit TTM $14.9 million
Return on assets TTM -40.28%
Return on equity TTM -737.71%
Profit margin 0%
Book value $-53.62
Market capitalisation $1.3 million

TTM: trailing 12 months

Quotient share dividends

We're not expecting Quotient to pay a dividend over the next 12 months.

Have Quotient's shares ever split?

Quotient's shares were split on a 1:40 basis on 2 November 2022. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Quotient shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Quotient shares which in turn could have impacted Quotient's share price.

Quotient share price volatility

Over the last 12 months, Quotient's shares have ranged in value from as little as $0.06 up to $68.8. A popular way to gauge a stock's volatility is its "beta".

QTNT.US volatility(beta: 2.19)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.1915. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Quotient overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. .

Frequently asked questions

What percentage of Quotient is owned by insiders or institutions?
Currently 2.115% of Quotient shares are held by insiders and 45.752% by institutions.
How many people work for Quotient?
Latest data suggests 450 work at Quotient.
When does the fiscal year end for Quotient?
Quotient's fiscal year ends in March.
Where is Quotient based?
Quotient's address is: Business Park Terre Bonne, Eysins, Switzerland, 1262
What is Quotient's ISIN number?
Quotient's international securities identification number is: JE00BLG2ZQ72
What is Quotient's CUSIP number?
Quotient's Committee on Uniform Securities Identification Procedures number is: G73268107

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site